The Use of Submucosal Dexamethasone After Periodontal Surgery

NCT06119893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-11-09

No results posted yet for this study

Summary

The aim of this study is to evaluate the effectiveness of submucosal 8 mg (2 mL) dexamethasone on postoperative pain, swelling, chewing efficiency, trismus, healing, and discomfort after periodontal flap surgery

Conditions

  • Periodontal Pocket
  • Pain
  • Swelling/ Edema
  • Patient Satisfaction
  • Periodontitis

Interventions

DRUG

submucosal 8 mg (2 mL) dexamethasone application

The mucoperiosteal flap was applied. After operation, submucosal dexamethasone 8 mg (2 mL) was applied to the operation area as a test group.

DRUG

submucosal 2 mL 0.9% isotonic sodium chloride application

The mucoperiosteal flap was applied. After operation, 2 mL 0.9% isotonic sodium chloride was applied to the operation area as a control group

Sponsors & Collaborators

  • Yuzuncu Yıl University

    lead OTHER

Principal Investigators

  • Dicle Altindal, DDS · Yuzuncu Yıl University

  • Anas ALSAFADI, PhD · Special dental clinic

  • Basem ALSHUJAA, PhD · Special dental clinic

  • Ahmet Cemil Talmac, PhD · Yuzuncu Yıl University

  • Bilal Ege, PhD · Adiyaman University

  • Metin Calisir, PhD · Adiyaman University

  • Nazli Zeynep Alpaslan, PhD · Yuzuncu Yıl University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-12
Primary Completion
2022-04-29
Completion
2022-04-29

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06119893 on ClinicalTrials.gov